|
|
|
Price: $0.8820
$-0.01 
-1.210%
|
| Day's High:
| $0.9018
| Week Perf:
| -5.16 %
|
| Day's Low: |
$ 0.87 |
30 Day Perf: |
-32.15 % |
| Volume (M): |
349 |
52 Wk High: |
$ 4.75 |
| Volume (M$): |
$ 308 |
52 Wk Avg: |
$0.93 |
| Open: |
$0.90 |
52 Wk Low: |
$0.25 |
|
|
| Market Capitalization (Millions $) |
13 |
| Shares
Outstanding (Millions) |
15 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
1 |
| Net Income (TTM) (Millions $) |
-13 |
| Cash Flow (TTM) (Millions $) |
-7 |
| Capital Exp. (TTM) (Millions $) |
0 |
Femasys Inc
Company Address: 3950 Johns Creek Court Suwanee 30024 GA
Company Phone Number: 500-3910 Stock Exchange / Ticker: NASDAQ FEMY
| FEMY is expected to report next financial results on March 29, 2024. |
|
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
|
Lakeland Industries Inc
Lakeland Industries Inc, a leading player in the industry, has recently shown remarkable strength in its financial performance. The company's income per share for the period August to October 31, 2023, witnessed a staggering surge of 78.95% to $0.34 per share. This impressive growth in income was accompanied by a notable increase in revenue of 11.593% to $31.68 million, compared to the previous year.
It is worth highlighting that this growth is even more remarkable when compared to the prior reporting season. During that period, income improved by 6.25% and revenue decreased by only -4.212%. This shows that Lakeland Industries Inc has successfully managed to enhance its financial position and ensure sustainable growth.
Furthermore, net earnings for the third quarter of 2024 experienced a remarkable surge of 82.95% from the same period a year ago. This increase, from $1.431 million to $2.618 million, clearly indicates the company's exceptional performance.
|
|
Aurora Technology Acquisition Corp
An Overview of Aurora Technology Acquisition Corp's Third Quarter Earnings
As the July to September 30, 2023 earnings season progresses, various companies across different industries are reporting their financial results. One such industry is the Medical Equipment and Supplies sector, which has seen many corporations release their earnings reports. Among them is Aurora Technology Acquisition Corp (ATAK), which recently announced an operating deficit of -$0.4793 million for the third quarter of 2023.
Comparing this figure to the same period in 2022, we can observe a deteriorating operating deficit. In the third quarter of 2022, ATAK reported an operating deficit of -$0.21933 million. This decline raises questions among market participants about the company's ability to generate revenue.
|
|
Vivos Therapeutics Inc
For the fiscal time-frame closing September 30 2023 Vivos Therapeutics Inc decreased a loss per share of $-1.75 per share compare to $-6.50 a year before and Income per Share improved from $-4.50 per share from the preceding reporting season. The revenue crumbled by -31.748 % to $2.90 million from $4.25 million in the corresponding reporting season a year before and sequentially Revenue decreased by -6.456 % from $3.10 million.
|
|
Vystar Corporation
Over the past five days, Vystar Corporation has experienced a significant drop in its stock price, declining by -37.78%. Furthermore, the stock is currently trading -20.9% below its 52-week average. In order to better understand the reasons behind this decline, it is essential to examine Vystar Corporation's financial performance for the recent reporting season, which ended on September 30, 2023.
Earnings Per Share and Revenue:
Vystar Corporation reported a considerable improvement in its financial health compared to the previous year. The loss per share decreased from $-0.23 to $-0.03, while the income per share improved from $-0.04. In terms of revenue, there was a significant decline of -98.311% from $3.57 million to $0.06 million compared to the same reporting season a year prior. However, sequentially, the revenue saw an increase of 67.054% from $0.04 million.
|
|
Petvivo Holdings Inc
As an investor closely following Petvivo Holdings Inc, the recent financial results have presented a mixed bag of challenges and opportunities. In the second quarter of 2024, the company experienced lower turnover, resulting in a significant revenue decrease and a larger shortfall per share compared to the previous year. However, there were notable signs of potential growth and increasing demand within the Medical Equipment and Supplies industry.
One of the key financial indicators is the revenue, which decreased by -7.127% to $0.21 million year on year. This decline is concerning for Petvivo Holdings Inc, as it points to potential shortcomings in the company's ability to generate sales. Comparatively, the Medical Equipment and Supplies industry as a whole recorded a top-line rise in the same period, suggesting that Petvivo may be facing certain internal challenges.
|
| Per Share |
Current |
| Earnings (TTM) |
-0.97 $ |
| Revenues (TTM) |
0.07 $
|
| Cash Flow (TTM) |
- |
| Cash |
0.58 $
|
| Book Value |
0.69 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.97 $
|
| Revenues (TTM) |
0.07 $ |
| Cash Flow (TTM) |
- |
| Cash |
0.58 $
|
| Book Value |
0.69 $ |
| Dividend (TTM) |
0 $ |
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights
reserved. This site uses cookies to make your browsing experince better. By
using this site, you agree to the Terms of Service and Privacy Policy - UPDATED
(Read about our Privacy Policy)
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
